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Abstract
We have previously reported that exposure of SH-SY5Y neuroblastoma cells to unconjugated bilirubin (UCB) resulted in a
marked up-regulation of the mRNA encoding for the Na
+ -independent cystine:glutamate exchanger System Xc
2 (SLC7A11
and SLC3A2 genes). In this study we demonstrate that SH-SY5Y cells treated with UCB showed a higher cystine uptake due
to a significant and specific increase in the activity of System Xc
2, without the contribution of the others two cystine
transporters (XAG
2 and GGT) reported in neurons. The total intracellular glutathione content was 2 folds higher in the cells
exposed to bilirubin as compared to controls, suggesting that the internalized cystine is used for gluthathione synthesis.
Interestingly, these cells were significantly less sensitive to an oxidative insult induced by hydrogen peroxide. If System Xc
2
is silenced the protection is lost. In conclusion, these results suggest that bilirubin can modulate the gluthathione levels in
neuroblastoma cells through the induction of the System Xc
2, and this renders the cell less prone to oxidative damage.
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Introduction
Unconjugated bilirubin (UCB) is a bile pigment produced in the
catabolism of hemoproteins. Heme oxygenase 1 and 2 catalyzes
the rate limiting step in bilirubin formation cleaving heme and
obtaining equimolar amounts of Fe
2+, CO and biliverdin [1,2].
The ubiquitous biliverdin reductase then reduces biliverdin to
bilirubin. UCB is a hydrophobic compound with extremely low
water solubility (#70 nM) [3] and is transported bound to serum
albumin to the liver where is conjugated with glucuronic acid in
the hepatocytes by the enzyme UGT1A1 and finally secreted into
the bile to be eliminated [4].
Newborn infants often show increased plasma levels of UCB. This
common condition, known as physiologic jaundice, is generally a
benign and transient phenomenon. In some cases, this hyperbiliru-
binemia can progress to bilirubin encephalopathy ranging from
minimal neurological injury to severe and permanent neurodevelop-
mental dysfunctions, condition knowing as kernicterus [5].
Bilirubin cell toxicity is determined primarily by the concen-
tration of the unbound (free) fraction of UCB (Bf) rather than total
bilirubin levels -(unbound and bound to albumin) [6]. Since UCB
can diffuse into any cell [7,8] and it is toxic at high concentrations
[9], all cells must maintain the intracellular quantity of UCB below
toxic concentrations. Since most cells are unable to conjugate
bilirubin, they have to oxidize and/or export UCB to prevent its
intracellular accumulation [10].
The precise mechanism of UCB-mediated cellular toxicity
remains unknown. Various observations suggest that the damage is
initiated at the level of membranes (plasma, mitochondrial, and
endoplasmic reticulum (ER)) with resultant perturbations of
membrane permeability and function [11–13]. These perturba-
tions will contribute to the genesis of neuronal excitotoxicity
[14,15], mithocondrial energy failure [16–21] and increased
intracellular Ca
2+ concentration [22]. Collectively, these three
phenomena and downstream events trigger cell death by both
apoptosis and necrosis. Process like DNA fragmentation, release of
cytochrome c, activation of caspase-3 and cleavage of poly(-
ADP)ribose polymerase has been described in bilirubin cell death
by apoptosis [12,23,24]. In addition, recent evidences demonstrate
that UCB-mediated apoptosis in Hepa 1c1c7 cells is associated
with oxidative stress [20] and in HeLa cells, the increase in
intracellular reactive oxygen species, due to UCB, activate a
signaling pathway involving APE1/Ref-1, Egr-1 and PTEN [25].
The oxidative stress involvement, after overstimulation of
glutamate receptors with the consequent increase in nNOS
expression and production of *NO radicals, has been recently
described [26].
In response to oxidative attack, cells have developed an
antioxidant defense system to maintain cellular redox homeostasis
and to protect cells from damage. The thiol-containing small
molecules (e.g. glutathione), reactive oxygen species-inactivating
enzymes (e.g. glutathione peroxidase), and phase 2 detoxifying
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involved in the reduction of reactive intermediates; c-glutamate
cysteine ligase (GCL) responsible for the biosynthesis of thiols and
stress response proteins like heme oxigenase 1 (HO-1)) are
members of this antioxidant system [27].
The major cellular antioxidant glutathione is an important line
of defense against reactive oxygen species and electrophiles [28].
Glutathione is a tripeptide containing the amino acids cysteine,
glutamate and glycine. Its synthesis is limited by availability of the
sulfhydryl amino acid cysteine, which is present in vitro as cystine in
the stock culture media (cysteine half-life: 0.5–1 h in the culture
medium) [29,30]. Both Na
+-dependent and Na
+-independent
processes are involved in translocation of cystine across the plasma
membrane in a wide range of cell types. In the presence of Na
+,
cystine is accumulated into the cells by high-affinity sodium
dependent cystine:glutamate transporter (System XAG
2) whereas,
principally in neurons, cystine transport occurs via the sodium
independent cystine:glutamate exchanger (System Xc
2) and the
sodium independent multifunctional enzyme cystine transporter
(GGT) [31,32].
Structurally, System Xc
2 is a member of the disulfide-linked
heterodimeric amino acid transporter family and consist of a light-
chain subunit (xCT, encoded by the SLC7A11 gene), which confers
substrate specificity [33], and a glycosylated heavy-chain subunit
(4F2hc, encoded by the SLC3A2) common to the transporter
family [34]. It transports cystine into cells in a 1:1 exchange with
glutamate and is inhibited by high concentrations of extracellular
glutamate. The activity of System Xc
2 is induced by various
stimuli, including electrophilic agents like diethylmaleate [35],
oxygen [36], bacterial lipopolysaccharide [37], cysteine and others
amino acids [38].
Recently, we have reported the effect of UCB exposure of SH-
SY5Y neuroblastoma cells on several genes by [39] and shown
that 230 genes were induced after 24 h of treatment. Since
SLC7A11 and SLC3A2 were among the strongest up-regulated
genes, we investigated the effect of UCB on both the expression
and the activity of the cystine transport systems (XAG
2,X c
2 and
GGT). The present data show that UCB elicits a functional
activation of the Xc
2 transport system which improves the
response of the cells to an oxidative stress insult.
Materials and Methods
Chemicals
Dulbecco’s Phosphate Buffered saline (PBS), streptomycin and
penicillin were purchased from Euroclone, Milan (Italy). Ham’s
Nutrient Mixture F12 (F12), Fetal calf serum (FCS) contained
54 mM albumin and GlutaMAX
TM obtained from Invitrogen
(Carlsbad, CA). Ham’s Nutrient Mixture F12 (F12), Eagle’s
Minimum Essential Medium (EMEM), nonessential amino acid
solution (MEM), dimethyl sulfoxide (DMSO), 3(4,5-dimethiltiazo-
lil-2)-2,5 diphenyl tetrazolium (MTT), L-buthionine-[S,R]-sulfox-
imine (BSO), NADPH, diethylmaleate (DEM), hydrogen peroxide
(H2O2), glutathione reductase (EC 1.8.1.7), 2,29-dinitro-5,59-di-
thiobenzoic acid (DTNB), L-quisqualic acid and Tri Reagent were
purchased from Sigma Chemical Co.-Aldrich, Milan (Italy).
Chloroform was obtained from Carlo Erba, Milan (Italy) and L-
[
14C]- cystine (9.25 GBq/mmol) was purchased from Perkin-
Elmer Life Sciences.
Unconjugated bilirubin (UCB) (Sigma Chemical Co, St. Louis
MO) was purified as described by Ostrow & Murkerjee [40]. UCB
required to reach the desired Bf (140 nM) was dissolved in 0.6%
v/v of DMSO and diluted in complete medium with 15% FCS. Bf
was measured as previously described [41].
Cell culture
SH-SY5Y human neuroblastoma cells (ATCC CRL-2266) were
cultured in a mixture of F12-EMEM (1:1) containing 15% (v/v)
foetal calf serum, 1% (v/v) non-essential amino acids, 1% (v/v)
GlutaMAX
TM, penicillin (100 U/mL) and streptomycin (100 mg/
mL) in 75 cm
2 tissue culture flasks at 37uC in a humidified
atmosphere of 5% CO2. The cells were fed every 2 days and
subcultured once they reached 80–90% confluence. Cultures were
stopped at the 20
th passage.
RNA isolation and quantification by quantitative real time
PCR (qPCR)
SH-SY5Y cells were seeded at 6610
6 cells in 75 cm
2 the day
before the experiment. Then, cells were exposed to the following
experimental conditions: free medium (untreated), 0.6% DMSO
medium or 140 nM Bf medium for 1, 4 and 24 h.
Total RNA was isolated by Tri Reagent solution according to
the manufacture’s suggestions (T9424, Sigma-Aldrich, Milan,
Italy). The total RNA concentration and the purity were
quantified by spectrophotometric analysis in a Beckman DU640.
For each sample the A260/A280 ratio comprised between 1.8 and
2.0 was considered as good RNA quality criteria. The integrity of
RNA was assessed on standard 1% agarose/formaldehyde staining
with ethidium bromide gel, indicating that the RNA preparations
were of high integrity. Isolated RNA was resuspended in RNAse
free water and stored at 280uC until the analysis.
Single stranded cDNA was obtained from 1 mg of purified RNA
using the iScrip
TMcDNA Synthesis Kit, according to the
manufacture’s suggestions. The reaction was run in a Thermal
Cycler (Gene Amp PCR System 2400, Perkin-Elmer, Boston, MA,
USA) in agreement with the reaction protocol proposed by the
manufacturer.
qPCR was performed according to the iQ SYBER Green
Supermix (Bio-Rad) protocol. PCR amplification was carried out
in 25 mL reaction volume containing 25 ng of cDNA, 16 iQ
SYBR Green Supermix (100 mM KCl; 40 mM Tris-HCl; pH:
8.4; 0.4 mM each dNTP; 40 U/mL iTaq DNA polymerase;
6 mM MgCl2; SYBR Green I; 20 mM fluorescein; and stabilizers)
(Bio-Rad Laboratories) and 250 nM of gene specific sense and
anti-sense primers. qPCR was performed with an iCycler IQ (Bio-
Rad Laboratories, Hercules, CA, USA), using b-actin, HPRT and
GAPDH as endogenous controls to normalize the expression level
of SLC7A11, GGT1 and SLC1A1 genes. Primer sequences and
references are reported in table 1. The primers were designed using
Beacon Designer 4.02 software (PREMIER Biosoft International,
Palo Alto, CA, USA).
Cycling parameters were determined and the results were
analyzed by using the comparative Ct method as the means of
relative quantification, normalized to the housekeeping gene and
expressed as 2
2DDCT. Melting curve analysis and gel electropho-
resis were performed to asses product specificity.
L-[
14C] Cystine uptake
SH-SY5Y cells were seeded in 6-multiwell plates at a density of
80.000 cell/cm
2. The day after the cells achieved a 70%
confluence and were subjected at 24 h treatment with 140 nM
Bf. The cells were then rinsed three times with warmed uptake
buffer (140 mM NaCl, 25 mM HEPES, 5.4 mM KCl, 1.8 mM
CaCl2, 0.8 mM MgSO4, 5 mM glucose (pH=7.5). For Na
+ -free
uptake, NaCl was replaced in the medium with an equal
concentration of N-metyl-D-glucamine chloride.
Cystine uptake by SH-SY5Y cells was started by incubating the
cells in uptake buffer containing 0.8 mM L-[
14C] cystine (L-
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14C]-Cystine, 250 mCi/mmol; PerkinElmer Italia Life and
Analytical Sciences) at 37uC during 0, 2, 5, 10 and 30 min. For the
subsequent experiments the analysis of Na
+-dependent and Na
+-
independent cystine transport, cells were incubated for a fixed time
period of 10 min. The uptake was terminated by rapidly rising
cells two times with ice-cold unlabelled uptake buffer. The cells
were then lysed by adding 0.8 mL of 0.2 N NaOH containing 1%
SDS. An aliquot of 50 mL was taken for protein determination.
The remaining solution (750 mL) was mixed with 5 mL of
scintillation cocktail (ULTIMA Gold
TM, Perkin Elmer Italia Life
and Analytical Sciences) and the radioactivity was determined
using a scintillation counter (Tri-Carb H Liquid Scintillation
Analyzer, Packard Instrument Company).
Glutathione determinations
SH-SY5Y cells were seeded in 60 mm diameter dish at a density
of 80.000 cell/cm
2. Once the cells achieved a 70% confluence
were subjected to the treatment for 24 h with free medium
(untreated), 0.6% DMSO medium or 140 nM Bf medium. Then
the cells were rinsed three times with PBS at 37uC and 500 mL ice-
cold 5% perchloric acid was added. The cells were detached by
scrapping, harvested, and the dishes rinsed twice with 500 mL ice-
cold 5% perchloric acid. All the fractions were pooled together,
homogenized and transferred to eppendorf tubes. The samples
were centrifugated at 13.000 g and the acid-soluble fraction was
separated from the pellet and both were stored at 280uC until
analysis were performed. The proteins were quantified using the
bicinchoninic acid assay from acid-precipitated pellet by treatment
with 1 M NaOH.
Reduced glutathione (GSH) plus oxidized glutathione (GSSG)
were measured as total glutathione content in the acid superna-
tants using an enzymatic method [42,43], after its neutralization
with a 0.76 M KHCO3. Briefly, supernatant aliquots (100 mL)
were assessed in 900 mL of the reaction mixture (0.1 M sodium
phosphate buffer (pH 7.5) containing 1 mM EDTA, 0.3 mM
DTNB, 0.4 mM NADPH). The rate of the enzymatic product
formation (Tiobenzoic acid=TNB) was monitored after the
addition of glutathione reductase (1 U/mL), in a termostated
cuvette (30uC), at 415 nm, for 3 min, with a Beckman DU 640
spectrophotometer. Glutathione concentrations were calculated
using appropriate standards and normalized by mg of protein.
Cell viability of SH-SY5Y Bf treated cells after hydrogen
peroxide stress
Cells were plated in 24-multiwell plates. Once they achieved a
70–80% confluence the growing medium was discarded, the cells
were rinsed with PBS at 37uC and exposed to medium containing
0.6% DMSO or UCB (Bf 140 nM) for 24 h. Then, the cells were
rinsed with PBS and maintained in optimal growth media until
hydrogen peroxide treatment was performed. Cell response to
hydrogen peroxide (0–700 mM) for 1 h was evaluated immediately
after Bf or DMSO treatment and at 156 h upon release in growth
medium. After the incubation with H2O2, the medium was
removed and replaced with culture medium containing MTT
0.5 mg/mL for 2 h [44]. Then, medium was discarded and MTT
formazan crystals were dissolved by adding 0.4 mL of DMSO.
The absorbance values at 570 nm were determined in a LD 400C
Luminescence Detector, Beckman Coulter, Milan, Italy. Results
were expressed as percentage of MTT reduction respect to cells
not exposed to H2O2.
Small interference RNA-mediated System Xc
2 (SLC7A11)
gene silencing
30000 SH-SY5Y cells/cm
2 (for DMSO treatment) or 60000
SH-SY5Y cells/cm
2 (for Bf treatment) were plated either in 24-
multiwell plates or in 6-multiwell plates for H2O2 treatment or
Western blot analysis, respectively. Cells were untransfected
(MOCK) or transfected with 50 nM siGENOME Non-Targeting
siRNA #1 (Dharmacon, Lafayette, CO, USA) (NT, silencing
control)n or with 50 nM siGENOME SMARTpool siRNA against
human SLC7A11 gene (Dharmacon, Lafayette, CO, USA) (anti-
xCT). 1.25 mL/well (for 24-multiwell plates) or 5 mL/well (for 6-
multiwell plates) of DharmaFECT 1 transfection reagent were
used, according to manufacturer’s instructions. Media were
changed after 24 h, and cells were growth for additional 24 h.
At this time, cells were rinsed once with PBS and exposed to
medium containing DMSO 0.6% or UCB (Bf 140 nM) for 24 h,
as previously described. Cells seeded in 24-multiwell plates
exposed to H2O2, and viability assessed by MTT-assay. Cells
seeded in 6-multiwell plates were lysed on-ice in 200 mL of cell
lysis buffer 16(Cell Signaling, Danvers, MA, USA) supplemented
with 1 mM PMSF and the total cell extracts were harvested by
scraping. The protein content of xCT in the cell extract was
assessed by Western blot analysis using an anti-xCT rabbit
polyclonal antibody (ab37185, Abcam, Cambridge, UK) and
normalized by actin protein content using an anti-actin antibody
(a2066, Sigma, Saint Louis, MO, USA). Bands were analized
using Kodak 1D image software and quantified by Scion image
software.
Statistical analysis
All experiments were performed in triplicate and repeated in at
least three different cell preparations. Results are expressed as
means 6 SD. One way ANOVA with Tukey–Kramer post-test
was performed using GraphPad InStat version 3.00 for Windows
95 (GraphPad Software, San Diego, CA, USA). Probabilities
,0.05 were considered statistically significant.
Table 1. List of primer sequences designed for the quantification of specific mRNAs by qPCR.
Gene Accession Number Primer Forward Primer Reverse Product (bp)
SLC7A11 NM_014331.3 GGTGGTGTGTTTGCTGTC GCTGGTAGAGGAGTGTGC 107
GGT1 NM_001032364.1 TCTCTGACGACACCACTC GACCTTGGAGCCAAAGTAG 152
SLC1A1 NM_004170.4 CCACTCTCATTGCTGCTGCTGTTATTC CATCCACCGTACTGACTTC 120
b-actin NM_001101 CTGGAAAGAATGTCTTGATTGTGG TTTGGATTATACTGCCTGACCAAG 120
HPRT NM_000194 CTGGAAAGAATGTCTTGATTGTGG TTTGGATTATACTGCCTGACCAAG 91
GAPDH NM_002046 CCCATGTTCGTCATGGGTGT TGGTCATGAGTCCTTCCACGATA 145
doi:10.1371/journal.pone.0029078.t001
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UCB treatment induces the expression of SLC7A11 (but
not SLC1A1 and GGT1) in SH-SY5Y cells
SH-SY5Y cells were treated with medium, 0.6% DMSO and
140 nM Bf for 1, 4 and 24 h, and the mRNA expression of the
genes involved in cystine uptake (SLC7A11, SLC1A1 and GGT1)
analyzed by qPCR. As shown in Figure 1, after 24 h of treatment
an induction of SLC7A11 was observed with a mRNA level 5 folds
higher (p,0.001) in respect to the controls (untreated cells and
0.6% DMSO); no changes in the expression was observed after 1
or 4 h of UCB treatment. On the contrary, the SLC1A1 gene
expression was decreased (p,0.01) 24 h after UCB treatment
while no change respect to controls (0.6% DMSO and untreated)
was observed at 1 and 4 h (Figure 1). The expression of GGT1 was
not affected by UCB treatment at any time in the study (Figure 1).
mRNA expression of others antioxidant proteins and phase II
enzymes, such as gamma-GCS (c-GCS), heme oxygenase-1 (HO-
1) and quinone oxidoreductase 1(NQO1),was also analyzed. The
exposure of cells to UCB resulted in an up-regulation of HO-1 (at
least 5 folds) only at 24 h and an up-regulation of c-GCS (at least 4
folds) only at 4 h. No changes on the expression of other enzymes
at 1, 4 and 24 h were found (data not shown).
L-[
14C] Cystine uptake by SH-SY5Y cells after UCB
treatment
Once shown that SLC7A11 mRNA expression is upregulated by
UCB, we examined whether the activity of the System Xc
2 was also
increased. Untreated SH-SY5Y, exposed to 0.6% DMSO or to
140 nM Bf cells for 24 h were incubated for 0, 2, 5, 10, and 30 min
with an uptake buffer containing 0.2 mCi/mL of L-[
14C] cystine
(0.8 mM) and cystine uptake measure therafter. The results are
reported in Figure 2. SH-SY5Y cells previously treated with UCB
showedacystineuptakesignificantlyhigherthancontrols(untreated
and 0.6% DMSO treated cells) over the course of 30 min. The
uptake in Bf treated cells was about 8 times higher than in controls
at 10 min and remained elevated thereafter. No difference was
observed between controls and cells exposed to DMSO.
Sodium -dependent and -independent cystine uptake
systems in SH-SY5Y cells treated with UCB
Considering that System XAG
2 is a sodium-dependent
transporter and System Xc
2 and GGT are sodium-independent
transporters we examined the relative contribution of each
transporter to the overall transport of L-cystine. We also evaluated
the contribution of System Xc
2 activity in total cystine uptake by
determining L-cystine transport by treating the cells with L-
quisqualate, a specific inhibitor of System Xc
2 [45]. Uptake of L-
[
14C] cystine was measured at 10 min in cells previously exposed
for 24 h to UCB (Bf 140 nM); cells exposed to 0.6% DMSO or
untreated were used as controls. The experiment was performed in
presence or absence of sodium ions (140 mM) and with or without
L-quisqualate (500 mM).
Figure 3 - panel A, shows that when all the transporters are
active (presence Na
+ and absence of L-quisqualate), cystine uptake
was about 8 times higher in Bf treated cells than controls, as also
shown in Figure 2. In presence of sodium and after L-quisqualate
addition (Figure 3 - panel B), L-cystine uptake in UCB treated cells
showed values similar to control cells (from 74.760.9 to
11.960.2 pmols/mg protein respectively, p,0.001). This result
suggests that System Xc
2 plays a major role in accounting for the
increased cystine uptake induced by UCB treatment.
When sodium was removed from the medium (Figure 3, panel
C) but in presence of L-quisqualate (System Xc
2 blocked), the
sodium dependent System XAG
2 was further inhibited leaving
cystine transport accounted only by GGT activity. Under these
conditions cystine uptake was not significantly decreased both in
controls (from 9.760.8 to 3.660.5 pmols/mg protein) and treated
cells (from 11.960.4 to 7.061.6 pmols/mg protein). These results
indicate that the contribution of System XAG
2 is not modified by
UCB treatment. When the activity of System Xc
2 is added to that
of GGT (absence of both Na
+ and L-quisqualate), L-cystine uptake
was again significantly higher in UCB treated than in control cells
(64.0612.6 pmols/mg protein vs 7.061.6 pmols/mg protein,
respectively, p,0.001) (Figure 3, panel D), indicating that only
System Xc
2 activity and not System XAG
2 and GGT activity is
induced by bilirubin treatment.
Effects of UCB treatment on intracellular GSH levels
Total glutathione was determined 1, 4 and 24 h after exposure
to140 nM Bf, DMSO and medium, the same time intervals used
in the study of the mRNA expression of the cystine transporters
(see Figure 1). GSH content was also evaluated after 24 h
treatment of the cells with 100 mM BSO or 100 mM DEM. The
glutathione extracted from the cells was mostly GSH, and the
content of GSSG was negligibly low in these studies, representing
only around of 2% of the total gluthathione content [46].
Figure 1. Effect of bilirubin on mRNA expression levels of genes involved in cystine uptake. SH-SY5Y cells exposed to free medium
(untreated), 0.6% DMSO medium or 140 nM Bf medium were collected after 1, 4 and 24 h of treatment. Specific mRNA expressions was analysed by
qPCR. mRNA expression is shown as mean 6 SD of 3 experiments relative to 1 h untreated control set at 1.0. **p,0.001 and *p,0.01 versus DMSO or
untreated controls.
doi:10.1371/journal.pone.0029078.g001
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0.6% DMSO medium or 140 nM Bf medium for 24 h. At the end of the treatment cells were incubated with L- [
14C] Cystine (0.8 mM) for 0, 2, 5, 10 and
30 min and uptake was evaluated and expressed as pmols/mg protein. Each point represents the mean 6 SD (n=3).
doi:10.1371/journal.pone.0029078.g002
Figure 3. Sodium –dependent and independent L-[
14C] cystine transport in SH-SY5Y cells. Transport activity was measured in control
(0.6% DMSO, 24 h) and treated (Bf 140 nM, 24 h) cells. L-[
14C] cystine (0.8 mM) uptake was measured after 10 min incubation at 37uC in the presence
and absence of sodium ions. L-quisqualate (500 mM) was used as a specific inhibitor for System Xc
2. Each point represents the mean 6 SD of three
plates of cells (** p,0.001).
doi:10.1371/journal.pone.0029078.g003
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in GSH levels were observed in SH-SY5Y cells treated with UCB
as compared to controls (0.6% DMSO or untreated cells). On the
contrary, after 24 h the total GSH content was 2 folds higher in
UCB treated cells than controls (25.165.3 vs. 7.660.6 and vs.
9.261.1 nmols/mg protein for DMSO and untreated cells,
p,0.01). As expected, GSH content was increased 4 folds after
treatment with DEM (GSH=41.565.8 nmols/mg protein) and
reduced 10 folds by BSO (GSH=0.8060.10 nmols/mg protein).
No changes in cell viability after BSO or DEM treatment were
detected by MTT test (data not shown) by any of the treatments.
Response of SH-SY5Y UCB treated cells to oxidative stress
Experiments were carried out to examine if the reductive
intracellular environment due to GSH increase content in UCB-
treated cells may be protective from an oxidative stress induced by
H2O2 treatment.
As shown in Figure 5 (upper panel A), the exposure for 60 min
to increasing concentrations of H2O2, of SH-SY5Y cells previously
treated with 0.6% DMSO for 24 h was followed by a dose-
dependent reduction in cell viability. On the contrary, cells
exposed for 24 h to 140 nM Bf showed a significantly lower
damage. At 600 mMo fH 2O2 the cell viability of control cells was
reduced by 80% while those exposed to UCB were not affected by
the treatment. This results are in agreement with the GSH cellular
content (lower panel A). Similar responses to H2O2 have been
observed when neuroblastoma cells were pre-exposed for 24 h
with 100 mM of DEM, a well known System Xc
2 activity inducer
(data not shown).
When cells pre-treated with 140 nM Bf for 24 h were left grown
for 156 h in the absence of UCB, the sensitivity to the H2O2-
induced oxidative stress was comparable to control cells (upper
panel B), and this was associated with GSH cellular level similar in
the two cell populations (lower panel B).
Response of UCB pre-treated SH-SY5Y cells to oxidative
stress after SLC7A11 gene silencing
To test the contribution of System Xc
2 to the cytoprotective
effects induced by UCB we performed experiments gene silencing
of SLC7A11 using siRNA. The expression of xCT protein
(55 kDa and 35 kDa) was studied in SH-SY5Y cells untransfected
(MOCK), transfected with not targeting siRNA (NT) and
transfected with siRNA against SLC7A11 gene (anti-xCT) after
24 h of Bf 140 nM or 0.6% DMSO treatment. Two bands were
observed, one at 35 kDa and the other at 55 kDa, the former
corresponding to the monomeric form of xCT and the latter
55 kDa, even if specific only to xCT if unknown function [47]. As
shown in Figure 6A, xCT protein expression was decreased only in
siRNA anti-xCT treatments (lanes 3 and 6). The expression of the
xCT band of 35 kDa was undetectable in DMSO treated cells
(Figure 6B, lane 3) and reduced by 88% in Bf treated cells
(Figure 6B, lane 6). Reduction of 55 kDa band was 89% in DMSO
treated cells (Figure 6B, lane 3) and 66% in Bf treated cells
(Figure 6B, lane 6).
Figure 6C shows the cytotoxic effects of 60 min exposure to
increasing concentration of H2O2 in DMSO or Bf pre-treated
cells, after SLC7A11 gene silencing. A dose-dependent reduction
in cell viability was observed for MOCK and NT groups. Pre-
exposure to Bf resulted in a significantly lower cytotoxicity than
DMSO pre-treated cells (p,0.05 at 300 mMH 2O2 and p,0.01 at
600 and 700 mMo fH 2O2. On the contrary, in anti-xCT group
(Figure 6C), the sensitivity to the oxidative stress was identical
Figure 4. Glutathione levels in SH-SY5Y cells treated with bilirubin. SH-SY5Y cells were exposed to free medium (untreated) or 0.6% DMSO
medium or 140 nM Bf medium and total intracellular content of gluthathione was determined after 1, 4 and 24 h. Results are expressed as mean 6
SD of 3 independent experiments performed in triplicate. *p,0.01 versus untreated and **p,0.001 versus 0.6% DMSO.
doi:10.1371/journal.pone.0029078.g004
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contribution of the System Xc
2 to the protection against H2O2
oxidative stress.
Discussion
In the present study we demonstrate, for the first time, that
UCB at a concentration found in jaundiced newborns is an
effective inducer of the activity of the System Xc
2 in SH-SY5Y
neuroblastoma cells. This increase in cystine uptake lead to higher
intracellular glutathione levels which protect the cell from an
oxidative stress.
We have previously reported an induction of SLC7A11 (xCT
subunit) and SLC3A2 (4f2hc subunit) gene expression in SH-
SY5Y cells after exposure to 140 nM Bf [39]. Here we extend this
study by showing that the up-regulation in the gene expression is
associated with a functional activation of the cystine transport
system described in literature in both astrocytes and neurons
[31,32,48]. The cystine transport is accounted by 3 different
mechanisms as System Xc
2 (SLC7A11), System XAG
2 (SLC1A1)
and the multifunctional ectoenzyme GGT (GGT1). Exposure to
UCB results in a marked gene and functional up-regulation of
System Xc
2 while the other 2 systems appear to be unchanged
both in terms of expression and activity.
In 1984, Bannai S. [35] described that electrophilic compounds
(diethyl maleate, sulfobromophthalein, ethacrynate) at relatively
low concentrations, caused an increase in cellular glutathione due
to the enhanced uptake of cystine via Na
+ independent transport
(designated as System Xc
2 by Makowske and Christensen in
human fibroblasts) [49]. It is noteworthy that cysteine is readily
converted to cystine by autooxidation [50]. Once inside the cell
cystine is rapidly reduced to cysteine, which is then incorporated
into proteins and glutathione. Because cysteine is a rate-limiting
precursor for glutathione synthesis, the intracellular regulation of
Figure 5. Response to H2O2 oxidative stress of SH-SY5Y cells pretreated with bilirubin and GSH intracellular levels of the cells
before H2O2 treatment. SH-SY5Y cells were exposed to two successive treatments: the first with 140 nM Bf (control with 0.6% DMSO medium) for
24 h. After this treatment, cells were released in growth medium for 156 h. Immediately after exposure to UCB (column A) and 156 h (column B) of
release, cells were incubated, as second treatment, with different concentrations of H2O2 for 60 min and viability evaluated by MTT. At each time
viability is expressed as a percentage of the controls considered as 100%. At each time viability results are compared with GSH intracellular levels of
the cells before H2O2 treatment. Results are expressed as media 6 SD of four different experiments.
doi:10.1371/journal.pone.0029078.g005
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2 activity is well defined
[51–53].
Sasaki et. al. [54] demonstrated in BHK21 cells that the activity
of System Xc
2 was significantly induced by various electrophilic
agents like diethyl maleate, arsenite, CdCl2, hydroquinone and
that the induction of xCT gene (the specific subunit of the System
Xc
2) was mediated by Keap1/Nrf2 pathway.
Data have been provided indicating the activation through
Keap1/Nrf2 pathway of the System Xc
2 by several electrophiles
together with others genes encoding phase II enzymes (Heme
oxygenase-1 or HO-1, NAD(P)H:quinine oxidoreductase or
NQO1, Multidrug resistance-associate protein 1 or MRP1, c-
glutamylcysteine synthetase or c-GCS, glutathione S-transferase
or GST, catalase or Cat) [55–58].
In our previous transcriptomic analysis [39], we speculate that
induction of System Xc
2 induced by UCB may represent a major
pro-survival response. In the present study we demonstrated that
the gene overexpression is functionally effective as associated with
a higher activity of the transporter. In a proteomic analysis
performed under the same experimental conditions used in this
study, Deganuto et. al. [59] described an increase of the expression
of proteins involved in cell proliferation (APMAP, APRT, WARS)
and that bilirubin decreased cellular growth rate, as a consequence
of DNA oxidative lesions. We observed after UCB exposure SH-
SY5Y cells start to growth in optimal growth media only 96 h after
of release (data not shown). Previous reports by Ollinger R et. al.
demonstrated that UCB acts as a natural inhibitor of proliferation
in vascular smooth muscle cells and HRT-18 colon cancer cells
[60,61].
The GSH level was significantly higher in treated UCB cells
respect to controls immediately after treatment when the cells were
not growing. Accordingly, UCB treated cells were able to respond
better than control cells to an oxidative stress induced by H2O2
treatment. GSH content returns to basal levels 156 h after the end
of treatment when the cells restart growing and the different
oxidative stress response between UCB treated and untreated cells
was lost. GSH is recognized as a general regulatory molecule with
several functions like the modification of proteins as part of normal
cell physiology and signaling [62–65]. Recent studies have shown
that intracellular reductive environment is the key requirement for
allowing DNA synthesis to occur [66].
We showed that cells exposed to UCB and containing high
GSH levels were resistant to an oxidative stress induced by H2O2
treatment. Previous evidence showed that bilirubin is a pigment
with antioxidant capacity at low concentration as described by
Dore ´ S. et. al. [67] in 1999 by studying the effect of nM
concentrations of UCB in the cytoprotection of primary
hippocampal cultures to H2O2. Furthermore, Baranano et al.
Figure 6. Response to H2O2 oxidative stress in xCT silenced SH-SY5Y cells pre-treated with bilirubin. Panel A: Protein expression of xCT
(55 kDa and 35 kDa) was analyzed by Western blot after siRNA and Bf treatment. Lane 1: MOCK and 0.6% DMSO; lane 2: NT and 0.6% DMSO; lane 3:
anti-xCT and DMSO 0.6%. Lane 4: MOCK and Bf 140 nM; lane 5: NT and Bf 140 nM ; lane 6: anti-xCT and Bf 140 nM. Panel B: Quantification of bands
shown in lanes from 1 to 6 of panel A. xCT 35 kDa and 55 kDa bands normalized by actin and expressed as relative to MOCK . Panel C) H2O2 dose-
response by MTT test was evaluated in untransfected (MOCK – left), transfected with not targeting siRNA (NT – middle) and transfected with siRNA
against SLC7A11 gene (anti-xCT - right) SH-SY5Y cells. After silencing, and before 1 h H2O2 treatment, SH-SY5Y cells were exposed for 24 h to 0.6%
DMSO or Bf 140 nM as indicated in the legend of each picture.
doi:10.1371/journal.pone.0029078.g006
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generated from biliverdin by biliverdin reductace in a redox cycle.
Recently Sedlak et. al. [69] demonstrated that bilirubin largely
protects against lipid peroxidation while GSH primarily prevents
the oxidation of water soluble proteins, and the possibility of
overlapping between the two mentionated systems.
Our data support the conclusion that UCB exposure may be
associated with a protection from an oxidative stress by increasing
the GSH cellular content and by modulating stress response
protein (i.e., HO-1). Regarding GSH homeostasis we observed an
early up-regulation of the rate limiting enzyme for GSH synthesis
c-GCS and an induction of the expression and the activity of the
System Xc
2 at 24 h. We also demonstrated that the cellular
response to and oxidative injury is abolished when xCT is silenced.
Increased HO-1 expression occurs under a wide range of
unrelated conditions that are characterized by alteration of the
cellular redox state [70].
Based on these data, we hypothesize that a subpopulation of
SH-SY5Y cell culture may bypass the first cytotoxic damage of
bilirubin by a combination of multiple mechanisms which include
the System Xc
2, maintaining a balanced redox environment
through GSH modulation. The surviving neuroblastoma cells not
only will restart the cell growth but also will be better suited to
respond to an external oxidative stress. Further investigations will
be necessary to understand the molecular pathways through which
bilirubin activates the System Xc
2 in our model.
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